Venus Concept Stock (NASDAQ:VERO)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$0.30

52W Range

$0.25 - $12.93

50D Avg

$0.59

200D Avg

$1.82

Market Cap

$578.19K

Avg Vol (3M)

$6.41M

Beta

-0.06

Div Yield

-

VERO Company Profile


Venus Concept Inc. is a medical technology firm that specializes in offering a range of innovative minimally and non-invasive solutions for medical aesthetics and hair restoration. Operating both domestically in the U.S. and internationally, the company is responsible for the development, market introduction, and ongoing provision of these advanced technologies and associated services. Its comprehensive product lineup features several cutting-edge devices: Venus Legacy: A non-invasive system primarily used in dermatological and general surgical procedures for female patients. Venus Versa: A versatile, multi-application platform designed for various aesthetic and cosmetic treatments. Venus Viva: A portable and advanced fractional radiofrequency (RF) system utilized in dermatological procedures for skin ablation and resurfacing. Venus Fiore: Employs non-thermal RF technology, combined with massage and magnetic field pulses, to address a variety of medical conditions. Venus Bliss: Targets non-invasive lipolysis of the abdomen and flanks, suitable for individuals with a body mass index (BMI) of 30 or below. Venus Glow: A specialized dermabrasion device aimed at enhancing overall skin appearance. NeoGraft: Provides advanced hair restoration using an automated Follicular Unit Extraction (FUE) and implantation system. Venus Velocity & Venus Epileve: These devices facilitate permanent hair removal, reduction, and the treatment of pseudofolliculitis barbae. ARTAS iX: A robotic system that assists physicians during hair transplantation by automating the identification, extraction, and implantation of follicular units from the scalp, as well as the creation of recipient sites. The company's corporate headquarters are located in Toronto, Canada.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

292

IPO Date

Oct 12, 2017

Website

VERO Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24Dec 23Dec 22
System$38.02M$41.87M$47.91M
Service$3.08M$3.41M$3.01M
Product$10.47M$10.56M$13.32M
Leases$13.27M$20.50M$35.27M

Fiscal year ends in Dec 24 | Currency in USD

VERO Financial Summary


Dec 24Dec 23Dec 22
Revenue$64.83M$76.35M$99.50M
Operating Income$-27.18M$-28.31M$-34.88M
Net Income$25.00K$-37.25M$-43.58M
EBITDA$-27.18M$-26.11M$-35.28M
Basic EPS$0.01$-6.84$-9.91
Diluted EPS$0.01$-6.84$-9.91

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q3 25Nov 13, 25 | 8:00 AM
Q2 25Aug 14, 25 | 5:00 PM
Q1 25May 15, 25 | 8:00 AM

Peer Comparison


TickerCompany
BGMSBio Green Med Solution, Inc.
BNBXBNB Plus Corp.
GRIGRI Bio, Inc.
NAOVNanoVibronix, Inc.
BBLGBone Biologics Corporation
NDRAENDRA Life Sciences Inc.
MOVECorvex, Inc.
DHAIDIH Holding US, Inc.
HSCSHeartSciences Inc.